Saturday, December 3, 2022

561.316.3330

Biotechnology News Magazine

Troomy Nootropics Launches Line of All-Natural, Functional Mushroom Gummies

New line of mushroom-powered gummies targets creating quick natural health benefits in the daily routine.

Latest Posts

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Venetoclax is a BCL-2 inhibitor approved by the U.S. Food and Drug Administration (FDA) for treatment of several hematologic cancers, including in combination with azacytidine for elderly patients with AML unable to tolerate the standard of care.

Acer Therapeutics Announces $1.5M Private Placement

The proceeds from the private placement will be used by Acer Therapeutics for working capital and general corporate purposes and, together with Acer’s existing cash and cash equivalents, are expected to be sufficient to fund the Company’s anticipated operating and capital requirements through the fourth quarter of 2022.

AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “The selection of ACI-35.030 for further development is a significant step for this collaboration. Early clinical testing showed that ACI-35.030 was generally well tolerated and induced specific activity against the pathological species of Tau, including the neurotoxic pTau and enriched paired helical filaments (ePHF) species, both of which are closely implicated in Alzheimer’s disease (AD).

TransCode Therapeutics Announces eIND Submission to US FDA for Planned First-in-Human Clinical Trial in Patients with Advanced Solid Tumors

The planned clinical trial is to evaluate TransCode’s lead therapeutic candidate, TTX-MC138, in cancer patients with advanced solid tumors. ​TTX-MC138 is designed to inhibit the pro-metastatic RNA, microRNA-10b, described as the master regulator of metastasis in a number of advanced solid tumors. TransCode Therapeutics believes that TTX-MC138 could be used as a treatment for many of these cancers.

This week, Southern California-based nootropics brand Troomy™ launches their highly anticipated line of adaptogenic mushroom gummies.

Made with the highest-quality, triple-extracted mushrooms, including Lion’s Mane, Reishi, and Cordyceps, Troomy™ Mushroom Gummies were consciously crafted to help reshape the daily routine while supporting a variety of vital health functions with an ultimate goal to help customers find their “True Me,” (what Troomy™ Founder, Bryan Garrison, refers to as a person’s “peak state of body and mind”).

Adaptogenic mushrooms, or “functional” mushrooms, are considered superfoods linked to improving daily function with vitamins, fibers, and antioxidants. These functional mushrooms like Lion’s Mane and Cordyceps have been used for centuries due to their nutrient-rich properties linked to supporting important bodily functions, including focus, sleep, relaxation, and more. Troomy™ Nootropics saw it was difficult for most consumers to get these mushrooms into their diet and decided to make them accessible, fun, and productive additions to the daily routine through gummies.

Formulated to help support a wide range of lifestyles and functional needs, Troomy™ Mushroom Gummies are available in a variety of super-powered mushroom blends and flavors:

Focus: Lion’s Mane Mushroom Gummies (Tangerine Passionfruit)
Boost: Cordyceps Mushroom Gummies (Lemon Lime)
Calm: Reishi Mushroom Gummies (Pineapple Peach)
Sleep: Reishi + Melatonin Gummies (Black Raspberry)
Daily: 14 Mushroom Blend Gummies (Strawberry Mango)

Made to meet the highest level of quality standards, Troomy™ Mushroom Gummies are blended in the United States, using premium, triple-extracted, functional mushrooms and other organic ingredients.

“We knew there was a difference-maker missing in our lives, and coffee just wasn’t doing the trick anymore. After years of operating in the health and wellness space, we’ve found that functional mushrooms are the answer. Today, unlocking your ‘True Me’ embodies that change we need in more than just a product, but a lifestyle,” says Garrison, “We wanted to create gummy nootropics that didn’t replace coffee or energy drinks, but simply made your daily routine easier, consistent, and more productive. After countless hours spent in research and development to get our blends just right, we’re proud to offer a premium quality product that we truly believe will help improve the lives of our customers.”

Troomy™ Mushroom Gummies will be available to purchase online from the brand’s online store, Troomy.com, beginning Oct. 11, 2022, and will ship to all states throughout the United States.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine